According to 180 Life Sciences's latest financial reports the company's current EPS (TTM) is -$23.95. In 2022 the company made an earnings per share (EPS) of -$19.34 a decrease over its 2021 EPS that were of -$14.36.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$23.95 | 23.84% |
2022 | -$19.34 | 34.68% |
2021 | -$14.36 | 8.79% |
2020 | -$13.20 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -90.90% | ๐บ๐ธ USA |